Peyronie’s disease is characterized by a plaque, or hard lump, that develops on the upper or lower side of the penis in layers containing erectile tissue. It starts with an inflammation and can develop into a hardened scar. Symptoms may develop slowly or appear overnight and they consist of reduced flexibility, pain, curved and shortened penis during erection.
The curvature of the penis generally leads to lowered self-esteem and makes sexual intercourse difficult, almost impossible.
Some of the factors involved in Peyronie’s disease can be: the existence of an infection, genetic predisposition, vascular problems, consumption of specific medicines, diabetes, hypertension, etc.
The plaque itself is benign, or noncancerous. However, if not treated, the disease may lead to a serious erectile dysfunction.
At first, the line of treatment for Peyronie’s disease was to “watch and wait” so as to find out whether the penile curvature resolved itself or worsened. When the latter occurred, the patient was given a vitamin E treatment, even though its positive outcome is not scientifically proved.
Researchers also have injected chemical agents into the plaques but here again; the procedure lacks scientific studies that prove its effectiveness.
A more effective way of curing Peyronie’s disease is surgery but it is considered a last resort because of the risks it carries (loss of erectile function, rigidity and shortening of the erect penis).
Luckily, surgery is not the only option to treat Peyronie’s disease and the patient suffering from the disease does not necessarily need to undergo a displeasing and risky surgery. Andromedical, a Spanish medical company, manufactures and distributes Andropenis®, a medical device using the principle of traction to straighten the penis with no side effect.
The first outcome should appear within three weeks of treatment and after 6 to 7 months, the patient will notice full results: a correction of up to 70 percent of the curvature. Thanks to its efficiency, Andropenis® benefits an important recognition from famous doctors all over the world, such as Doctor Wayne Hellstrom, Chief of Andrology at Tulane University School of Medicine in New Orleans. Moreover, many scientific studies guarantee the efficiency of Andropenis® in cases of Peyronie’s disease.
Apart from rectifying penile curvatures, Andropenis® can also be used as a penile postoperative treatment in order to avoid scar retraction and especially to achieve a penis enlargement of 3 to 4 centimetres (1.2 to 1.6 inches) in length as well as a girth increase of 1,5 centimetre (0.6 inch) with a 97.5 percent rate of efficiency as demonstrated by independent scientific research around the globe.
For more information about Andromedical and Andropenis®, please visit
Media Contact:
Nicolas Defretin
media@andromedical.com